Paying users zone. Data is hidden behind: .
Get 1-month access to Abbott Laboratories for $19.99, or
get full access to the entire website for at least 3 months from $49.99.
This is a one-time payment. There is no automatic renewal.
Common-Size Balance Sheet: Liabilities and Stockholders’ Equity
Abbott Laboratories, common-size consolidated balance sheet: liabilities and stockholders’ equity
|Balance sheet item||Description||The company|
|Current liabilities||Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.||Abbott Laboratories’s current liabilities as a percentage of total liabilities and shareholders’ investment increased from 2018 to 2019 and from 2019 to 2020.|
|Long-term liabilities||Amount of obligation due after one year or beyond the normal operating cycle, if longer.||Abbott Laboratories’s long-term liabilities as a percentage of total liabilities and shareholders’ investment decreased from 2018 to 2019 but then slightly increased from 2019 to 2020.|
|Total liabilities||Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.||Abbott Laboratories’s total liabilities as a percentage of total liabilities and shareholders’ investment decreased from 2018 to 2019 but then increased from 2019 to 2020 exceeding 2018 level.|
|Total Abbott shareholders’ investment||Total of all stockholders’ equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity’s stockholders’ equity attributable to the parent excludes the amount of stockholders’ equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.||Abbott Laboratories’s total Abbott shareholders’ investment as a percentage of total liabilities and shareholders’ investment increased from 2018 to 2019 but then decreased significantly from 2019 to 2020.|